Phosphatidylethanolamines are the Main Lipid Class Altered in Red Blood Cells from Patients with VPS13A Disease/Chorea‐Acanthocytosis
Movement Disorders · 2025
DOI: 10.1002/mds.30086 ↗Kurz gefasst
Fachartikel in der Zeitschrift Movement Disorders, 2025. Verfasst von Kevin Peikert und 7 weiteren Autor:innen. Beteiligte Einrichtung: Translational Neurodegeneration Section "Albrecht Kossel", Department of Neurology, University Medical Center Rostock, University of Rostock, Rostock…. Hauptthemen laut MEDLINE: Neuroacanthocytosis, Erythrocytes, Vesicular Transport Proteins, Phosphatidylethanolamines. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: MeDDrive TU Dresden.
Abstract (Originalsprache)
Background
VPS13A disease is an ultra‐rare disorder caused by loss of function mutations in VPS13A characterized by striatal degeneration and by red blood cell (RBC) acanthocytosis. VPS13A is a bridge‐like protein mediating lipid transfer at membrane contact sites.
Objectives
To assess the lipid composition of patient‐derived RBCs.
Methods
RBCs collected from 5 VPS13A disease patients and 12 control subjects were analyzed by mass spectrometry (lipidomics).
Results
While we found no significant differences in the overall lipid class level, alterations in certain species were detected: phosphatidylethanolamine species with both longer chain length and higher unsaturation were increased in VPS13A disease samples. Specific ceramide, phosphatidylcholine, and sphingomyelin species were also altered.
Conclusions
The presented alterations of particular lipid species in RBCs in VPS13A disease may contribute to (1) the understanding of acanthocyte formation, and (2) future biomarker identification. Lipid distribution seems to play a key role in the pathophysiology of VPS13A disease. © 2024 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Translational Neurodegeneration Section "Albrecht Kossel", Department of Neurology, University Medical Center Rostock, University of Rostock, Rostock, Germany.
- Center for Transdisciplinary Neurosciences Rostock (CTNR), University Medical Center Rostock, Rostock, Germany.
- United Neuroscience Campus Lund-Rostock (UNC), Rostock, Germany.
- Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.
- Department of Neurology, Technische Universität Dresden, Dresden, Germany.
- Deutsches Zentrum für Neurodegenerative Erkrankungen, Dresden, Germany.
ORCID-Profile: Kevin Peikert, Gabriel Miltenberger-Miltenyi, Andreas Hermann
Förderung
- MeDDrive TU Dresden
Zitieren
APA
Peikert, K., Spranger, A., Miltenberger-Miltenyi, G., Glaß, H., Falkenburger, B., Klose, C., Tyteca, D., & Hermann, A. (2025). Phosphatidylethanolamines are the Main Lipid Class Altered in Red Blood Cells from Patients with VPS13A Disease/Chorea‐Acanthocytosis. Movement Disorders. https://doi.org/10.1002/mds.30086
Vancouver
Peikert K, Spranger A, Miltenberger-Miltenyi G, Glaß H, Falkenburger B, Klose C, et al. Phosphatidylethanolamines are the Main Lipid Class Altered in Red Blood Cells from Patients with VPS13A Disease/Chorea‐Acanthocytosis. Movement Disorders. 2025. doi:10.1002/mds.30086
BibTeX
@article{Peikert2025,
author = {Peikert, Kevin and Spranger, Adrian and Miltenberger-Miltenyi, Gabriel and Glaß, Hannes and Falkenburger, Björn and Klose, Christian and Tyteca, Donatienne and Hermann, Andreas},
title = {Phosphatidylethanolamines are the Main Lipid Class Altered in Red Blood Cells from Patients with VPS13A Disease/Chorea‐Acanthocytosis},
journal = {Movement Disorders},
year = {2025},
doi = {10.1002/mds.30086}
}
EUVIMED